This week’s UK tech investments showcase a diverse range of innovative ventures, marking significant growth in the sector.
- PhoreMost, a health tech company from Cambridge, secured Series B funding to enhance its drug discovery platform.
- Twenty7tec, a fintech firm based in Bournemouth, received growth equity VC investment to streamline mortgage processes.
- Solasta Bio, known for its ‘nature-inspired’ solutions, attracted investors with its innovative insecticides.
- Delli, an independent food ecommerce service, caught the attention of investors for its unique market approach.
This week’s UK tech funding activities highlight the dynamic nature of the sector, with a total of £106.5 million in investments—a remarkable 130% increase from the previous week. Among the key players, PhoreMost stood out by attracting Series B funding from major investors including BGF, XtalPi Inc, Astellas Venture Management, and more. This Cambridge-based health tech enterprise continues to revolutionize the drug discovery landscape with its cutting-edge platform.
Twenty7tec, a promising fintech company headquartered in Bournemouth, focused on optimizing the mortgage journey, secured significant growth equity VC investment. This funding underscores the importance of technological innovation in streamlining traditionally cumbersome financial processes.
Investors also expressed confidence in Solasta Bio, which stands out for its commitment to sustainability with ‘nature-inspired’ insecticides. This creative approach to pest control has resonated with investors looking to support environmentally responsible technologies.
In the food tech domain, Delli captured the interest of investors with its independent ecommerce platform, which offers a unique approach to the online food market. Their strategy caters to a growing segment of consumers seeking more diverse and independent food options.
The week’s diverse funding rounds reflect a burgeoning confidence in the UK’s tech innovations across multiple sectors.
